US Patent

US12357642 — Hazardous agent injection system

Formulation · Assigned to Antares Pharma Inc · Expires 2030-03-19 · 4y remaining

Vulnerability score 61/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a hazardous agent injection system, specifically designed for use with a powered injector.

USPTO Abstract

Injection systems comprising a powered injector and one or more hazardous agents are disclosed.

Drugs covered by this patent

chembl-chembl34259 (METHOTREXATE)

Patent Metadata

Patent number: US12357642
Jurisdiction: US
Classification: Formulation
Expires: 2030-03-19
Drug substance claim: No
Drug product claim: Yes
Assignee: Antares Pharma Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.